Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana, Cuba

被引:18
作者
Montalvo Villalba, Maria C. [1 ]
Guan, Ming [2 ]
Perez, Antonio [1 ]
Bello Corredor, Marite [1 ]
Sariego Frometa, Susel [1 ]
Gutierrez Moreno, Aidonis [1 ]
Hu, Wei P. [2 ]
Howard, Teresa
Rodriguez Lay, Licel A. [1 ]
Anderson, David
机构
[1] Inst Trop Med Pedro Kour IPK, Natl Reference Lab Viral Hepatitis, Havana, Cuba
[2] MP Biomed Asia Pacific Pte Ltd, Singapore, Singapore
关键词
Hepatitis; Hepatitis E virus; anti-HEV; epidemiology; risk factors; Cuba; BLOOD-DONORS; INFECTION; HEV; IDENTIFICATION; EPIDEMIOLOGY; PREVALENCE; PIG;
D O I
10.1016/j.trstmh.2010.08.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hepatitis E virus (HEV) infection is an important cause of acute viral hepatitis in tropical and sub-tropical regions that occurs both as epidemic episodes and sporadic cases. The aim of this investigation was to estimate the prevalence of total immunoglobulin (Ig) anti-hepatitis E virus (anti-HEV) and the risk factors associated to two communities in Havana City. Serum samples (n = 469) obtained from healthy individuals with no history of viral hepatitis were screened for total anti-HEV by enzyme immunoassay (EIA). An overall prevalence of 10% (47/469) (95% Cl: 7.52-13.19%) was obtained. Higher anti-HEV prevalence was found in the municipality of Marianao (12.1%) compared to Playa (7.1%). Analysis of risk factors revealed a significant association of total anti-HEV prevalence in age group 41-60 years old, with a risk ratio of 3.21 (95% Cl: 1.09-9.7) (P=0.01). No relation was found between anti-HEV and other variables such as gender, risk occupations, surgery and transfusions. The detection of total anti-HEV in individuals with no overt acute hepatitis suggests the existence of sub-clinical or anicteric HEV infection in these municipalities. (C) 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:772 / 776
页数:5
相关论文
共 31 条
[1]  
Abe Kenji, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P90
[2]  
Aboulata Alaa A, 2005, Egypt J Immunol, V12, P71
[3]   Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea [J].
Ahn, JM ;
Kang, SG ;
Lee, DY ;
Shin, SJ ;
Yoo, HS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3042-3048
[4]   Seroepidemiology of hepatitis E virus infection in Mexican subjects 1 to 29 years of age [J].
Alvarez-Muñoz, MT ;
Torres, J ;
Damasio, L ;
Gómez, A ;
Tapia-Conyer, R ;
Muñoz, O .
ARCHIVES OF MEDICAL RESEARCH, 1999, 30 (03) :251-254
[5]   Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, Southwest Iran [J].
Assarehzadegan, Mohammad Ali ;
Shakerinejad, Ghodratollah ;
Amini, Akram ;
Rezaee, S. A. Rahim .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (04) :387-390
[6]   Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia [J].
Bartoloni, A ;
Bartalesi, F ;
Roselli, M ;
Mantella, A ;
Arce, CC ;
Paradisi, F ;
Hall, AJ .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1999, 4 (09) :596-601
[7]  
Bortoliero André Luiz, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P87, DOI 10.1590/S0036-46652006000200006
[8]   HEPATITIS-E - EPIDEMIOLOGY, ETIOLOGY AND MOLECULAR-BIOLOGY [J].
BRADLEY, DW .
REVIEWS IN MEDICAL VIROLOGY, 1992, 2 (01) :19-28
[9]   Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain [J].
Buti, Maria ;
Dominguez, Angela ;
Plans, Pere ;
Jardi, Rossend ;
Schaper, Melani ;
Espunes, Jordi ;
Cardenosa, Neus ;
Rodriguez-Frias, Francisco ;
Esteban, Rafael ;
Plasencia, Antoni ;
Salleras, Luis .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (12) :1328-1332
[10]  
Chow W. C., 1996, Singapore Medical Journal, V37, P579